📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: A mendelian randomization analysis (2018)

First Author: Ference B

Attributed to: Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.895

Publication URI: http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.895

Type: Journal Article/Review

Parent Publication: Atherosclerosis